Department of Centre for Nuclear Medicine

Department of Centre for Nuclear Medicine

On 14thJune 2024, Dr. Sudeep Gupta, Director – TATA Memorial Centre, inaugurated ‘Nuclear Medical Centre’ for cancer diagnosis and treatment in a grand ceremony at B. K. L.Walwalakar Hospital and Medical College; Srishetra – Dervan. On this occasion, Ms. Riddhi Bhatia, Mr. Yogesh Karmarkar, representatives of Kotak Mahindra Bank, who has given huge financial support to this centre; Ms. Chitra and Ms. Hemadri Buzruk of Rama- Purushottam Trust, Officers of Nana Palkar Trust, Dr. Shripad Banavali, Director (Academic), Tata Memorial Centre, Mumbai; Executive Trustee of Vitthalrao Joshi Charities Trust Shri. Vikasrao Walawalkar and Chief Trustee, Shri. Ashokrao Joshi, Medical Director of Dervan Hospital Dr. Suvarna Patil, Dean of, B.K.L. Walawalkar
Medical College Dr. Mansingh Ghatage, Dr. Rita Mulherkar, and much more dignitaries, faculty, staff, students and locals were present. Chief Guest Dr. Sudeep Gupta and his wife Dr. Sumedha Gupta, including the guests of honor, had reached Dervan the evening before. All of them were given a tour o the medical college, and in the college’s conference hall, Dr. Suvarna Patil gave an elaborate presentation to the guests about the philanthropic work that the Trust undertakes in a variety of fields. Each guest took an interested look around the hospital. The “Nuclear Medicine Centre,” which is 6500 square feet in size and features PET and SPECT facilities in addition to high and low doses of nuclide therapy, is being inaugurated today; in a recently built multi-storey structure. Every structure, including walls, floors, and ceilings, etc. are 230 mm, as advised by the AERB, made of substantial reinforced concrete. 6.10 X 7.5 m for SPECT and PET imaging. Size rooms have been built with a separate electrical room, radio pharmacy, dose administration room,
waiting area, safe radioactive waste storage system, and separate room for radioactive material storage. Attached labs are also included. Here, the heart’s muscle strength is also assessed through a “stress test.” A separate room has been set up for patients receiving high dose therapy. According to AERB standards, two 6000-liter tanks are constructed for contaminated miles. The people of Konkan will be benefitted from PET-CT ScanF-18, FDGF-18, PSMAF-18, Cardiac Viability, and SPECT Scan for Renal, Cardiac, Liver, Bone, Thyroid, GE Reflux, Lung Perfusion scan, lodine therapy for thyroid disorders etc

List of Test

Sr. No.Test / Therapy NameOPD / IPDIndication / Details
1F-18 FDG PET CT (CECT)OPDBenign & Malignant tumors
2F-18 FDG PET CT (NCCT)OPDBenign & Malignant tumors with elevated serum creatinine, sarcoma, lymphoma
3Cardiac FDG PET CTOPDViability
4F-18 DOPA PET CTOPDBrain tumors, epilepsy, etc.
5PSMA PET CTOPDCa prostate
6SSR PET CTOPDNET
7Myocardial Perfusion Imaging (MPI)-MIBI scan (Rest & Stress)OPDViability
8Pertechnetate Thyroid scintigraphyOPDGraves disease & Thyroiditis
9Bone scintigraphyOPDBenign & Malignancy
10Three Phase bone scanOPDCellulitis, osteomyelitis
11Parathyroid scintigraphyOPDAdenoma, Hyperplasia
12DTPA scanOPDObstructive Uropathy
13DMSA scanOPDInfections, Absolute Function
14EC scanOPDMRD, Renal Failure
15Lung PerfusionOPDPulmonary embolism
16Radioiodine scanOPDPost Thyroidectomy
17m-IBG ScanOPDPheochromocytoma and neuroblastomas.
Therapy Procedures
18Radioiodine therapy
(Low dose 10 mCi / 15 mCi)
OPDGrave’s disease
19Radioiodine therapy (High Dose)
• 50 mCi
• 100 mCi
• 150 mCi
• 200 mCi
• 250 mCi
Indoor stay • Papillary Carcinoma
• Papillary Carcinoma with nodal mets
• Papillary Carcinoma with lung mets, Follicular carcinoma
20PRRT (Lu-177) DOTA TATE therapy
• 100 mCi
• 200 mCi
Day careCRPC
20PRRT (Lu-177) PSMA therapy
• 100 mCi
• 200 mCi
Day careCa prostate
21m-IBG therapy (100 mCi)Indoor stayPheochromocytoma and neuroblastomas.

Click Here to view brochure

Translate »
Blogger